Use of levodopa decarbox-comt-inhibitor

PDMED_LEVODOPA_DECARBOX_COMTINHIBITOR

No definition available.

Endpoint definition

FinnGen phenotype data

321302 individuals

diagram downward connector

Apply sex-specific rule None

321302

diagram downward connector

Check conditions None

321302

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC N04BA03

765

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

605

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

605

diagram downward connector

Include endpoints None

605

diagram downward connector
PDMED_LEVODOPA_DECARBOX_COMTINHIBITOR

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
?
Number of individuals
594 217 377
?
Unadjusted prevalence (%)
0.19 0.13 0.28
?
Mean age at first event (years)
68.41 67.11 69.16

?
Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

0102050607080020406080100120140160180200ageindividuals

Year distribution of first events

19701975198019851990199520002005201020152021020406080100120140160180200220yearindividuals

Cumulative Incidence

Correlations

Index endpoint: PDMED_LEVODOPA_DECARBOX_COMTINHIBITOR – Use of levodopa decarbox-comt-inhibitor
GWS hits:

Survival analyses between endpoints

Plot

before Use of levodopa decarbox-comt-inhibitor
after Use of levodopa decarbox-comt-inhibitor

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Use of levodopa decarbox-comt-inhibitor